COR
Cencora, Inc. Healthcare - Medical Distribution Investor Relations →
Cencora, Inc. (COR) closed at $271.83 as of 2026-06-19, trading 15.8% above its 200-week moving average of $234.63. The stock is currently moving closer to the line, down from 20.4% last week. With a 14-week RSI of 28, COR is in oversold territory.
Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.70 ratio) is neutral — neither side is clearly dominating.
Over the past 1580 weeks of data, COR has crossed below its 200-week moving average 20 times. On average, these episodes lasted 11 weeks. Historically, investors who bought COR at the start of these episodes saw an average one-year return of +11.9%.
With a market cap of $52.9 billion, COR is a large-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at 107.1%, indicating strong profitability. The stock trades at 15.6x book value.
The company has been aggressively buying back shares, reducing its share count by 5.9% over the past three years.
Over the past 30.3 years, a hypothetical investment of $100 in COR would have grown to $10301, compared to $1954 for the S&P 500. That represents an annualized return of 16.5% vs 10.3% for the index — confirming COR as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $1,065,040.
Free cash flow has been growing at a 13.3% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: COR vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After COR Crosses Below the Line?
Across 20 historical episodes, buying COR when it crossed below its 200-week moving average produced an average return of +13.1% after 12 months (median +7.0%), compared to +10.8% for the S&P 500 over the same periods. 80% of those episodes were profitable after one year. After 24 months, the average return was +42.2% vs +17.9% for the index.
Each line shows $100 invested at the moment COR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices COR would reach each dislocation threshold.
Dislocation Price Levels
Prices where COR's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-05.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $249.33 | Unusually cheap — potential buy zone |
| Value | +1σ | $279.39 | Cheap vs. own history |
| Fair Value | +0σ | $317.68 | Historical mean behavior |
| Expensive | -1σ | $368.13 | Expensive vs. own history |
| Deep Expensive | -2σ | $437.64 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from COR's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
COR has crossed below its 200-week MA 20 times with an average 1-year return of +11.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 1999 | Jun 2000 | 38 | 53.6% | +58.0% | +6819.7% |
| Mar 2003 | Mar 2003 | 1 | 0.5% | +20.4% | +3526.3% |
| Dec 2003 | Feb 2004 | 6 | 2.2% | +8.9% | +3036.3% |
| Mar 2004 | May 2004 | 8 | 6.9% | +7.5% | +2911.7% |
| May 2004 | May 2004 | 1 | 1.1% | +14.0% | +2820.5% |
| Jun 2004 | Dec 2004 | 24 | 16.3% | +14.9% | +2795.5% |
| Dec 2004 | Apr 2005 | 18 | 7.4% | +44.2% | +2874.3% |
| Jun 2008 | Jul 2008 | 5 | 5.6% | -7.0% | +1935.8% |
| Sep 2008 | Aug 2009 | 50 | 27.9% | +6.2% | +1893.6% |
| Oct 2016 | Nov 2016 | 2 | 11.3% | +12.4% | +425.4% |
| Dec 2016 | Jan 2017 | 3 | 1.8% | +22.5% | +367.3% |
| Apr 2017 | Apr 2017 | 1 | 0.6% | +12.5% | +343.2% |
| Jul 2017 | Nov 2017 | 17 | 11.7% | +2.0% | +343.6% |
| Mar 2018 | Apr 2018 | 4 | 3.2% | -4.6% | +321.1% |
| Apr 2018 | Jun 2018 | 6 | 4.5% | -5.4% | +309.7% |
| Jun 2018 | Jul 2018 | 1 | 2.7% | +3.4% | +313.2% |
| Jul 2018 | Aug 2018 | 5 | 7.9% | +5.9% | +316.0% |
| Sep 2018 | Sep 2018 | 1 | 2.3% | +2.0% | +308.7% |
| Oct 2018 | Oct 2018 | 1 | 3.7% | +9.1% | +314.1% |
| Dec 2018 | Jun 2019 | 26 | 17.6% | +11.5% | +314.2% |
| Average | 11 | — | +11.9% | — |
Frequently Asked Questions
Is COR below its 200-week moving average?
No. Cencora, Inc. (COR) is currently 15.8% above its 200-week moving average of $234.63. It would need to fall to $234.63 to cross below the line.
What is COR's 200-week moving average price?
Cencora, Inc.'s 200-week moving average is $234.63 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when COR drops below its 200-week moving average?
COR has crossed below its 200-week moving average 20 times in our data. On average, buying at that moment produced a one-year return of +11.9%. These dips have historically been decent entry points. These episodes lasted 11 weeks on average.
Is COR a good value right now?
Here's what our data says about COR as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 28 (oversold). Free cash flow is currently negative. Return on equity is 107.1%. Price-to-book is 15.6x. This is not a buy or sell recommendation — always do your own research.
How does COR compare to the S&P 500?
Over the past 30.3 years, $100 invested in COR would have grown to $10301, compared to $1954 for the S&P 500. That's 16.5% annualized vs 10.3% for the index. COR has outperformed the broader market over this period.
Does COR pay a dividend?
Yes. Cencora, Inc. currently pays a dividend yield of 85.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19